Significant effort has been invested to enhance the effector functions of exhausted cells; indeed, checkpoint inhibitors, targeting various of the above-mentioned co-inhibitory receptors, are very efficient in improving CD8 T-cell numbers and effector function of exhausted CD8 T cells in both cancer and chronic infections9. Here, CD8A is linked to cancer.